Literature DB >> 16003709

Circadian rhythm of spectral indices of heart rate variability in healthy subjects.

Andrzej Bilan1, Agnieszka Witczak, Robert Palusiński, Wojciech Myśliński, Janusz Hanzlik.   

Abstract

Circadian pattern of heart rate variability spectral indices, including hourly, 24-hour, night, day, morning, and sex-adjusted measures of low frequency (LF), high frequency (HF), and LF/HF, was evaluated in healthy persons in 24-hour 3-lead electrocardiogram. HF showed circadian pattern with the greatest night values and LF/HF with the smallest night values. Peaks of hourly LF were found between 5 and 9 am and between 4 and 6 pm. The smallest LF was between 11 pm and 3 am. Hourly HF peaked between 11 pm and 5 am. The smallest HF was observed between midday and 2 pm. LF/HF peaked between 6 and 9 am as well as between 4 and 6 pm with the smallest values between midnight and 5 am. Sex adjustment was of no significance. In healthy subjects, HF and LF/HF have circadian pattern. Evaluation of all 5-minute intervals of 24-hour period seems to be a precise method of heart rate variability analysis.

Entities:  

Mesh:

Year:  2005        PMID: 16003709     DOI: 10.1016/j.jelectrocard.2005.01.012

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  20 in total

1.  Childhood obesity and autonomic dysfunction: risk for cardiac morbidity and mortality.

Authors:  Duanping Liao; Sol M Rodríguez-Colón; Fan He; Edward O Bixler
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-10

2.  Spectro-Temporal Electrocardiogram Analysis for Noise-Robust Heart Rate and Heart Rate Variability Measurement.

Authors:  Diana P Tobon; Srinivasan Jayaraman; Tiago H Falk
Journal:  IEEE J Transl Eng Health Med       Date:  2017-12-04       Impact factor: 3.316

3.  The circadian pattern of cardiac autonomic modulation and obesity in adolescents.

Authors:  Sol Rodríguez-Colón; Fan He; Edward O Bixler; Julio Fernandez-Mendoza; Alexandros N Vgontzas; Arthur Berg; Yuka Imamura Kawasawa; Duanping Liao
Journal:  Clin Auton Res       Date:  2014-10-31       Impact factor: 4.435

4.  ECG and Heart Rate Variability in Sleep-Related Breathing Disorders.

Authors:  Hua Qin; Fernando Vaquerizo-Villar; Nicolas Steenbergen; Jan F Kraemer; Thomas Penzel
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

5.  Neurobehavioral Symptoms and Heart Rate Variability: Feasibility of Remote Collection Using Mobile Health Technology.

Authors:  Andrew Nabasny; Amanda Rabinowitz; Brittany Wright; Jijia Wang; Samuel Preminger; Lauren Terhorst; Shannon B Juengst
Journal:  J Head Trauma Rehabil       Date:  2022-02-01       Impact factor: 3.117

6.  Autonomic nervous system function and depth of sedation in adults receiving mechanical ventilation.

Authors:  Takeshi Unoki; Mary Jo Grap; Curtis N Sessler; Al M Best; Paul Wetzel; Anne Hamilton; Karen G Mellott; Cindy L Munro
Journal:  Am J Crit Care       Date:  2009-01       Impact factor: 2.228

Review 7.  Review and classification of variability analysis techniques with clinical applications.

Authors:  Andrea Bravi; André Longtin; Andrew J E Seely
Journal:  Biomed Eng Online       Date:  2011-10-10       Impact factor: 2.819

8.  Influences of age, gender, and circadian rhythm on deceleration capacity in subjects without evident heart diseases.

Authors:  Ruifu Zhao; Dan Li; Ping Zuo; Rong Bai; Qiang Zhou; Jingjing Fan; Chengpeng Li; Lin Wang; Xiaoyun Yang
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-08-12       Impact factor: 1.468

Review 9.  The end effector of circadian heart rate variation: the sinoatrial node pacemaker cell.

Authors:  Yael Yaniv; Edward G Lakatta
Journal:  BMB Rep       Date:  2015-12       Impact factor: 4.778

10.  Chaotic signatures of heart rate variability and its power spectrum in health, aging and heart failure.

Authors:  Guo-Qiang Wu; Natalia M Arzeno; Lin-Lin Shen; Da-Kan Tang; Da-An Zheng; Nai-Qing Zhao; Dwain L Eckberg; Chi-Sang Poon
Journal:  PLoS One       Date:  2009-02-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.